0.6 vs. 1.2 mg Atropine Together With Neostigmine 2.5 mg on Heart Rate in Patient Receiving Muscle Relaxant

Clinical trial NCT02186132 · COMPLETED

Trial details

NCT number: NCT02186132
Sponsor: Mahidol University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Bradycardia Neostigmine Adverse Reaction Adverse Reaction to Belladonna or Atropine

Start date: 2012-03-01
Primary completion: 2013-02-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.